Scoop: Juno recruits Sunil Agarwal as R&D chief, opening a Bay Area facility in research revamp
Hans Bishop, CEO of Juno Therapeutics Victor J. Blue/Bloomberg via Getty Images
A troubled Juno Therapeutics $JUNO has recruited ex-Genentech scientist Sunil Agarwal to head up a revamped R&D organization as the Seattle-based biotech sets out to establish a San Francisco group to help rev up its work on the biotech’s leading CAR-T therapies and get back on target after its lead program jumped the tracks, Endpoints News has learned.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.